XpresSpa Group Appoints David Kohel to Newly Created Chief Technology Officer Position
December 01 2020 - 4:05PM
XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”),
a health and wellness company, today announced that it has named
David Kohel as its Chief Technology Officer, a newly created
position at the Company. In this role, he will be responsible for
all aspects of developing technology to support the Company’s
long-term opportunity of building the leading global Travel Health
and Wellness brand.
“David is a great addition to our leadership
team and brings to us extensive technology experience in driving
innovation along with demonstrated success,” said Doug Satzman,
XpresSpa Group CEO. “His customer-centric approach aligns perfectly
with our vision of creating a new business that leverages our
historic Travel Wellness experience and new-found Healthcare
expertise, enabling us as a category leader in providing travelers
with peace of mind. We are very excited to have someone of David’s
caliber join XpresSpa in this new role.”
Mr. Kohel is a driven c-level technology
executive with a 22 year proven track record delivering new and
disruptive products to market for industry giants including Nike,
Kroger, and a late-stage startup, ZOOM+Care. He has deep experience
in product development, strategy, technology transformation, data
science, building high-performing teams, turnaround operations,
mergers & acquisitions, and helping companies successfully
scale.
Mr. Kohel is the Founder of Theory Venture
Partners, a venture capital and private equity advisory, and
currently serves as a Board Member at Vytal Health, a whole person
health care company, and as an Advisor to Q5id, Inc., a company
that protects businesses and consumers against identity theft and
fraud. He holds a Bachelor of Arts from the University of
Delaware.
About XpresSpa Group, Inc.
XpresSpa Group, Inc. (Nasdaq: XSPA) is a leading
global health and wellness holding company. XpresSpa Group’s core
asset, XpresSpa, is a leading airport retailer of spa services and
related health and wellness products, with 50 locations in 25
airports globally. Through its XpresTest, Inc. subsidiary, the
Company also provides COVID-19 screening and testing, rapid testing
services for other communicable diseases that include influenza,
mononucleosis and group A streptococcus, and flu vaccination
services under its XpresCheck™ brand. Current XpresCheck Wellness
Centers include JFK International Airport, Newark Liberty
International Airport, Logan International Airport, and Phoenix Sky
Harbor International Airport. To learn more about XpresSpa Group,
visit: www.XpresSpaGroup.com. To learn more about XpresSpa, visit
www.XpresSpa.com. To learn more about XpresCheck, visit
www.XpresCheck.com.
Investor Relations:ICRRaphael
Grossir@xpresspagroup.com(203) 682-8253
Media:Julie
FergusonJulie@jfprmedia.com(312) 385-0098
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Aug 2024 to Sep 2024
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Sep 2023 to Sep 2024